Evaluation of the Covid-19 vaccination process in Family Health Centers: A descriptive study
Introduction and Aim: To overcome the effects of the Covid-19 pandemic, in Turkey, the inactivated vaccine Sinovac/Coronovac and the mRNA vaccine Pfizer/BioNTech have been applied since January 13, 2021 and April 12, 2021 respectively. Especially with the introduction of Pfizer/BioNTech vaccine, which contains more than one dose in one vial, various problems have been experienced during the delivery, storage and application of the vaccine. This study aims to understand the challenges faced by practitioners in the Covid-19 vaccination process in Family Health Centers (FHC), determine the factors causing these difficulties and the solutions produced by the practitioners, and discuss how similar problems encountered in vaccination processes are addressed by the strategies and the methods in the industrial engineering literature.
Materials and Methods: A descriptive study was planned. Family physicians and family health workers working in the FHC and vaccinating against Covid-19 formed the universe of the research. The sample was not calculated, the participants were accessed via online platforms (Google forms). Data were collected between 10.8.2021 and 10.10.2021. The frequency distributions of the data were calculated in Microsoft® Excel® for Microsoft 365 MSO (Version 2203 Build 16.0.15028.20152) 64-bit program.
Results: Our research was conducted with a total of 124 FHC employees. Of these, 102 (82.2%) are physicians and 22 (17.8%) are other healthcare professionals. To the question “What are the factors that reduce the effectiveness of the vaccination that you experience during the Covid-19 vaccination process?” we asked the participants, 80.6% answered that 6 people to be vaccinated should wait to open a vial. 75.2% of the participants stated that they worked without taking a break during the day to overcome the problems during the Covid-19 vaccination process.
Conclusion: Various problems related to vaccine logistics and management have been identified such as the requirement of gathering six people to be able to administer the Pfizer/BioNTech vaccine, the inability to design an effective appointment system, and the conflicts of the routine work of FHCs and the vaccine administration tasks. These problems can be handled and solved with the strategies and methods commonly used in the industrial engineering literature.
References
- WHO Coronavirus (COVID-19) Dashboard | WHO Coronavirus (COVID-19) Dashboard With Vaccination Data [Internet]. [cited 2021 Jul 12]. https://covid19.who.int/ adresinden 14.02.2022 tarihinde erişilmiştir.
- T.C. Sağlık Bakanlığı COVID-19 Bilgilendirme Platformu Covid19 [Internet]. [cited 2021 Dec 7]. https://covid19.saglik.gov.tr/ adresinden 14.02.2022 tarihinde erişilmiştir.
- Greenwood B. The contribution of vaccination to global health: past, present and future. http://dx.doi.org/10.1098/rstb.2013.0433 adresinden 24.03.2022 tarihinde erişilmiştir.
- Fine P, Eames K, Heymann DL. “‘Herd Immunity’”: A Rough Guide. [cited 2021 Dec 7] https://academic.oup.com/cid/article/52/7/911/299077 adresinden 24.03.2022 tarihinde erişilmiştir.
- WHO. Immunization coverage [Internet]. [cited 2021 Dec 7]. https://www.who.int/en/news-room/fact-sheets/detail/immunization-coverage adresinden 24.03.2022 tarihinde erişilmiştir.
- Mallory ML, Lindesmith LC, Baric RS, Hill C. Vaccination-induced herd immunity: Successes and challenges. 2018 [cited 2021 Dec 7] https://doi.org/10.1016/j.jaci.2018.05.007 adresinden 14.02.2022 tarihinde erişilmiştir.
- Plans P, Torner N, Godoy P, Jané M. Lack of herd immunity against measles in individuals aged <35 years could explain re-emergence of measles in Catalonia (Spain). Int J Infect Dis [Internet]. 2014 [cited 2021 Dec 7];18:81–3. http://dx.doi.org/10.1016/j.ijid.2013.09.015 adresinden 14.02.2022 tarihinde erişilmiştir.
- On Kwok K, Lai F, In Wei W, Yeung Shan Wong S, Tang JW. Herd immunity – estimating the level required to halt the COVID-19 epidemics in affected countries. 2020 [cited 2021 Dec 7] https://doi.org/10.1016/j.jinf.2020.03.027 adresinden 24.03.2022 tarihinde erişilmiştir.
- Dai L, Gao GF. Viral targets for vaccines against COVID-19. Nat Rev Immunol 2021;21(2):73–82. http://dx.doi.org/10.1038/s41577-020-00480-0 adresinden 24.03.2022 tarihinde erişilmiştir.
- Hürriyet Gazetesi. Son dakika haberler: Pfizer-Biontech aşıları uygulanmaya başlandı – İşte Biontech aşısı hakkında detaylar [Internet]. [cited 2021 Dec 7]. https://www.hurriyet.com.tr/gundem/pfizer-biontech-asisi-hakkinda-merak-edilenler-41778462 adresinden 24.03.2022 tarihinde erişilmiştir.
- Vaccine hesitancy: Definition, scope and determinants | Elsevier Enhanced Reader [Internet]. [cited 2021 Dec 7]. https://reader.elsevier.com/reader/sd/pii/S0264410X15005009?token=A649F6E34E412203C8C672E5DA1348D3440B254AC43C2BB89F22C44C03C3C45F8BED033DE72B450C0E941A3A55578445&originRegion=eu-west-1&originCreation=20211207194739 adresinden 24.03.2022 tarihinde erişilmiştir.
- Kilic M, Ustundag ON, Uslukilic G. The relationship of Covid-19 vaccine attitude with life satisfaction, religious attitude and Covid-19 avoidance in Turkey. Hum Vaccin Immunother 2021 Oct 3;17(10):3384-93. https://doi.org/10.1080/21645515.2021.1938493 adresinden 24.03.2022 tarihinde erişilmiştir.
- Yigit M, Ozkaya-Parlakay A, Senel E. Evaluation of COVID-19 Vaccine Refusal in Parents. Pediatr Infect Dis J 2021;40(4):134–6.
- Hürriyet Gazetesi. TURKOVAC aşısı çıktı mı, ne zaman uygulanacak? TURKOVAC aşısı hakkında bilgiler [Internet]. [cited 2021 Dec 7]. https://www.hurriyet.com.tr/galeri-turkovac-asisi-cikti-mi-ne-zaman-uygulanacak-turkovac-asisi-hakkinda-bilgiler-41947063/2 adresinden 24.03.2022 tarihinde erişilmiştir.
- Türkiye’de COVID-19 aşılaması – Vikipedi [Internet]. [cited 2022 Apr 25]. https://tr.wikipedia.org/wiki/Türkiye%27de_COVID-19_aşılaması adresinden 24.03.2022 tarihinde erişilmiştir.
- T.C. Sağlık Bakanlığı. Aşılarda faz çalışmaları ne ifade eder? [Internet]. [cited 2022 Apr 25]. https://covid19asi.saglik.gov.tr/ adresinden 24.03.2022 tarihinde erişilmiştir.
- Salvendy G. Handbook of Industrial Engineering: Technology and Operations Management. 1. Baskı. John Wiley & Sons, Inc. 2001. https://onlinelibrary.wiley.com/doi/book/10.1002/9780470172339 adresinden 24.03.2022 tarihinde erişilmiştir.
- Duijzer LE, van Jaarsveld W, Dekker R. Literature review: The vaccine supply chain. Eur J Oper Res 2018;268(1):174–92. https://doi.org/10.1016/j.ejor.2018.01.015 adresinden 24.03.2022 tarihinde erişilmiştir.
- Patel K, Nayak B, Rana S, Krishnan P, Tandale BV, Basak S, et al. Enablers and barriers towards ensuring routine immunization services during the COVID-19 pandemic: findings from a qualitative study across five different states in India. Trans R Soc Trop Med Hyg 2022;0:1–8.
- Ares-Blanco S, Astier-Peña MP, Gómez-Bravo R, Fernández-García DY, José M, Bueno-Ortiz M. Gestión de los recursos humanos y estrategias de vacunación en atención primaria en Europa en la pandemia COVID-19. Atención Primaria 2021;53:102132.
- Aile sağlığı merkezlerinde BioNTech aşısı yapılmaya başlandı [Internet]. [cited 2022 Apr 11]. https://www.aa.com.tr/tr/koronavirus/aile-sagligi-merkezlerinde-biontech-asisi-yapilmaya-baslandi/2268172 adresinden 24.03.2022 tarihinde erişilmiştir.
- Alsuhaibani M, Alaqeel A. Impact of the COVID-19 Pandemic on Routine Childhood Immunization in Saudi Arabia. [cited 2022 Apr 25]. www.mdpi.com/journal/vaccines adresinden 24.03.2022 tarihinde erişilmiştir.
- İkiışık H, Sezerol MA, Taşçı Y, Maral I. COVID-19 vaccine hesitancy: A community-based research in Turkey. Int J Clin Pract 2021 Aug;75(8):e14336.
- Haldane V, Zhang Z, Abbas RF, Dodd W, Lau LL, Kidd MR, et al. National primary care responses to COVID-19: A rapid review of the literature. BMJ Open 2020;10(12):e041622.
- Hovav S, Tsadikovich D. A network flow model for inventory management and distribution of influenza vaccines through a healthcare supply chain. Oper Res Heal Care 2015;5:49–62.
- Rastegar M, Tavana M, Meraj A, Mina H. An inventory-location optimization model for equitable influenza vaccine distribution in developing countries during the COVID-19 pandemic. Vaccine 2021;39(3):495–504.
- Li X, Pan Y, Jiang S, Huang Q, Chen Z, Zhang M, et al. Locate vaccination stations considering travel distance, operational cost, and work schedule. Omega 2021;101:102236. https://doi.org/10.1016/j.omega.2020.102236 adresinden 24.03.2022 tarihinde erişilmiştir.
- Kokshagina O, Abbasi B, Fadaki M, Saeed N, Chhetri P. Modeling Vaccine Allocations in the COVID-19 Pandemic: A Case Study in Australia. 2020. https://scholar.google.ru/citations?view_op=view_citation&hl=vi&user=YT8vb-0AAAAJ&citation_for_view=YT8vb-0AAAAJ:hMod-77fHWUC adresinden 24.03.2022 tarihinde erişilmiştir.